BioFuse Medical Technologies

Bio Fuse Medical Technologies

Medical Devices, 6767 N. Wickham Road, MELBOURNE, Florida, 32940, United States, 1-10 Employees

biofusemedical.com

  • LinkedIn

phone no Phone Number: +35***********

Who is BIOFUSE MEDICAL TECHNOLOGIES

BioFuseTM is a new RF tissue sealing and welding technology. Using transformative technology which is proven in Europe in 1000s of cases, this surgical innovation replaces traditional met...

Read More

map
  • 6767 N. Wickham Road, MELBOURNE, Florida, 32940, United States Headquarters: 6767 N. Wickham Road, MELBOURNE, Florida, 32940, United States
  • 2013 Date Founded: 2013
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 7379 | NAICS Code: 541519 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BIOFUSE MEDICAL TECHNOLOGIES

BioFuse Medical Technologies Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding BioFuse Medical Technologies

Answer: BioFuse Medical Technologies's headquarters are located at 6767 N. Wickham Road, MELBOURNE, Florida, 32940, United States

Answer: BioFuse Medical Technologies's phone number is +35***********

Answer: BioFuse Medical Technologies's official website is https://biofusemedical.com

Answer: BioFuse Medical Technologies's revenue is $1 Million to $5 Million

Answer: BioFuse Medical Technologies's SIC: 7379

Answer: BioFuse Medical Technologies's NAICS: 541519

Answer: BioFuse Medical Technologies has 1-10 employees

Answer: BioFuse Medical Technologies is in Medical Devices

Answer: BioFuse Medical Technologies contact info: Phone number: +35*********** Website: https://biofusemedical.com

Answer: BioFuseTM is a new RF tissue sealing and welding technology. Using transformative technology which is proven in Europe in 1000s of cases, this surgical innovation replaces traditional methods of sutures, staples and electrosurgical vessel sealing. Biofuse Technology Can address a broad range of clinical applications in many disciplines Has a robust pipeline of products in various stages of development. Already has an FDA 510(k) clearance for vessel sealing, solid IP protection and an arsenal of trade secrets Market Data This technology is serving a large and growing target market of $3 billion. Market Data indicates a strong and growing demand for advanced, innovative devices that facilitate evolving surgical procedural techniques and vastly improve patient outcomes. Surgeons are looking for the new solutions, the new technology that will eliminate scars and lower infection rates. There is also an increased demand to replace or monitor staples that are under recall. An FDA report from March 2019 indicated 41,000 adverse event reports for staplers from 2011 2018. There is also a continued focus on MIS to reduce hospital stays and thereby reduce hospital costs for the patients. Technology BioFuse Technology addresses the clinical challenges that surgeons face by delivering sophisticated, advanced algorithm-controlled energy to surgical instruments. The Technology Promotes: Leak Proof continuous tissue to tissue connection Revascularization to improve blood flow Technology Lowers OR Time

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access